The company should report only facts, like they have been doing recently. Facts like study results, new hires or fires, discrete plans, financial status or required bureaucratic reports needed by the different authorities.
They should not go down any rabbit holes denying or affirming possible misinformation depending on the CEO's judgement of how that data may affect the company. Generally the less said the better.
Irritating for the inquisitive stockholders looking for clues but much better for the brass running the CYDY boat who are seeing and developing the big picture.
I trust JL to do the right things for leronlimab and indirectly for us I know patience is getting thin but patience is what will get us to the finish line.